Canada
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.58 B
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
2 |
USD 49.90 M
|
Dec. 31, 2023 | USD 30.84 | 0.81% |
|
Canada |
|
3 |
USD 36.13 M
|
Dec. 31, 2023 | USD 23.94 | 0.98% |
|
Canada |
|
4 |
USD 28.55 M
|
Dec. 31, 2023 | USD 13.41 | 0.42% |
|
Canada |
|
5 |
USD 20.38 M
|
Dec. 31, 2023 | USD 9.40 | -4.39% |
|
Canada |
|
6 |
USD -214.00 K
|
March 31, 2024 | USD 3.11 | 5.40% |
|
Canada |
|
7 |
USD -2.86 M
|
Dec. 31, 2023 | USD 1.25 | -0.34% |
|
Canada |
|
8 |
USD -4.08 M
|
Dec. 31, 2023 | USD 1.51 | -0.70% |
|
Canada |
|
9 |
USD -4.51 M
|
Dec. 31, 2023 | USD 2.82 | -2.42% |
|
Canada |
|
10 |
USD -6.17 M
|
Sept. 30, 2024 | USD 1.59 | -8.09% |
|
Canada |
|
11 |
USD -7.32 M
|
Nov. 30, 2024 | USD 1.93 | -6.31% |
|
Canada |
|
12 |
USD -10.87 M
|
Dec. 31, 2023 | USD 0.11 | 0.09% |
|
Canada |
|
13 |
USD -11.96 M
|
Oct. 31, 2023 | USD 1.51 | -1.31% |
|
Canada |
|
14 |
USD -12.70 M
|
Dec. 31, 2023 | USD 3.69 | 0.40% |
|
Canada |
|
15 |
USD -16.89 M
|
Dec. 31, 2023 | USD 2.12 | -1.09% |
|
Canada |
|
16 |
USD -18.80 M
|
March 31, 2024 | USD 0.91 | -2.78% |
|
Canada |
|
17 |
USD -20.94 M
|
Dec. 31, 2023 | USD 0.82 | -3.10% |
|
Canada |
|
18 |
USD -21.22 M
|
Dec. 31, 2023 | USD 1.25 | -1.98% |
|
Canada |
|
19 |
USD -23.96 M
|
Nov. 30, 2023 | USD 1.71 | 4.46% |
|
Canada |
|
20 |
USD -27.53 M
|
Dec. 31, 2023 | USD 2.70 | 2.33% |
|
Canada |
|
21 |
USD -28.21 M
|
Dec. 31, 2023 | USD 3.02 | 1.15% |
|
Canada |
|
22 |
USD -28.54 M
|
Sept. 30, 2024 | USD 1.77 | 2.31% |
|
Canada |
|
23 |
USD -28.57 M
|
Dec. 31, 2023 | USD 7.26 | -2.32% |
|
Canada |
|
24 |
USD -29.82 M
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
25 |
USD -33.58 M
|
Sept. 30, 2024 | USD 1.53 | -2.45% |
|
Canada |
|
26 |
USD -51.16 M
|
March 31, 2024 | USD 1.82 | -9.45% |
|
Canada |
|
27 |
USD -51.18 M
|
March 31, 2024 | USD 3.94 | -2.21% |
|
Canada |
|
28 |
USD -55.14 M
|
Oct. 31, 2024 | USD 7.58 | -5.96% |
|
Canada |
|
29 |
USD -57.04 M
|
Dec. 31, 2023 | USD 0.94 | 1.68% |
|
Canada |
|
30 |
USD -57.64 M
|
March 31, 2024 | USD 8.83 | -0.79% |
|
Canada |
|
31 |
USD -59.69 M
|
Dec. 31, 2023 | USD 1.96 | -0.51% |
|
Canada |
|
32 |
USD -78.02 M
|
Dec. 31, 2023 | USD 7.55 | -2.83% |
|
Canada |
|
33 |
USD -93.80 M
|
Dec. 31, 2023 | USD 1.27 | -3.05% |
|
Canada |
|
34 |
USD -95.73 M
|
Dec. 31, 2023 | USD 6.40 | -1.54% |
|
Canada |
|
35 |
USD -118.67 M
|
Dec. 31, 2023 | USD 13.62 | -2.44% |
|
Canada |
|
36 |
USD -146.40 M
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
37 |
USD -182.39 M
|
Dec. 31, 2023 | USD 39.65 | 3.66% |
|
Canada |
|
38 |
USD -244.98 M
|
May 31, 2024 | USD 1.18 | -0.37% |
|
Canada |
|
39 |
USD -260.00 M
|
Dec. 31, 2023 | USD 17.23 | -0.99% |
|
Canada |
|
40 |
USD -485.20 M
|
March 31, 2024 | USD 2.23 | -6.78% |
|
Canada |
|
41 |
USD -592.00 M
|
Dec. 31, 2023 | USD 7.49 | 1.16% |
|
Canada |
|
42 |
USD -1.68 B
|
Sept. 30, 2024 | USD 4.08 | -3.32% |
|
Canada |
The Pharmaceuticals company in Canada with the highest Net Income is Loblaw Companies Limited (Toronto Stock Exchange: L.TO) at USD 1.58 B.
The Pharmaceuticals company in Canada with the lowest Net Income is InMed Pharmaceuticals Inc. (NasdaqCM: INM) at USD -1.68 B.
The top 10 Pharmaceuticals companies in Canada by Net Income are Loblaw Companies Limited, Andlauer Healthcare Group Inc., Jamieson Wellness Inc., Savaria Corporation, Cipher Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., XORTX Therapeutics Inc., CareRx Corporation, Sunshine Biopharma, Inc. and Edesa Biotech, Inc..
The bottom 10 Pharmaceuticals companies in Canada by Net Income are InMed Pharmaceuticals Inc., Bausch Health Companies Inc., Canopy Growth Corporation, Bausch + Lomb Corporation, Tilray Brands, Inc., Xenon Pharmaceuticals Inc., AbCellera Biologics Inc., Zymeworks Inc., Mind Medicine (MindMed) Inc. and Repare Therapeutics Inc..